Treatment of Anemia With Intravenous Iron in Patients Listed for Orthotopic Liver Transplantation
Status:
Recruiting
Trial end date:
2023-05-31
Target enrollment:
Participant gender:
Summary
The aim of this study is to investigate whether therapy with intravenous iron carboxymaltose
in patients with iron deficiency anemia (IDA) listed for orthotopic liver transplantation
(OLT) increases hemoglobin concentrations and reduces intraoperative transfusion of packed
red blood cells (PRBCs). The investigators hypothesize that therapy with intravenous iron
will increase hemoglobin concentrations and reduce intraoperative transfusion of PRBCs in
patients with IDA listed for OLT.